ArticlemBio2021

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.

Shiho Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.